选择性终止自依赖癌症的选择性终止
Ajit Roy1, Melvin L DePamphilis2
1National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Room 6N105, 10 Center Dr., Bethesda, MD 20892-0001, USA.
Cells
|July 12, 2024
概括
癌细胞依靠自细胞生存,与正常细胞不同. PIKFYVE 抑制剂通过破坏 lysosome 稳态来选择性地向这些癌细胞,提供了一个有前途的癌症疗法,副作用最小.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌细胞表现出独特的代谢需求,导致对自的生存和增殖的依赖.
- 细胞自和细胞贩运由酸酸调节,使它们的合成酶成为潜在的治疗点.
- PIKFYVE 抑制剂通过破坏 lysosome 稳态来显示对癌细胞的选择性毒性.
研究的目的:
- 为了阐明PIKFYVE敏感细胞和不敏感细胞之间的生化差异.
- 根据其化学结构,特异性和有效性对PIKFYVE抑制剂进行分类.
- 了解选择性癌细胞终结的机制,并探索治疗应用.
主要方法:
- 对PIKFYVE敏感和不敏感细胞的生物化学分析.
- 将PIKFYVE抑制剂分为不同的组.
- 对选择性癌细胞杀死机制的研究.
- 在癌症模型中评估治疗潜力.
主要成果:
- 确定了使癌细胞具有选择性向的生化特征.
- 分类PIKFYVE抑制剂,显示有效性和特异性的差异.
- 通过抑制剂终止自依赖癌细胞的阐明机制.
- 在癌症免疫治疗中观察到矛盾效应.
结论:
- PIKFYVE 抑制剂代表了对自取决于癌症的向治疗.
- 了解抑制机制对于优化癌症治疗至关重要.
- 对PIKFYVE抑制剂的进一步研究可能会提高癌症免疫疗法和治疗结果.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Delivery Pathways to the Lysosome
6.2K
Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.2K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


